Investment
Features
FeesSafety
Academy
More
Pluang+

Peoples Bancorp to report Q3 2026 earnings on Oct 20 with live call and webcast

Company Fundamentals
28 Sep 2026
PRNewsWire
View Source
Neutral
Peoples Bancorp to report Q3 2026 earnings on Oct 20 with live call and webcast

Peoples Bancorp Inc. announced it will release its third quarter 2026 earnings before the market opens on October 20, 2026. The company will hold a conference call at 11:00 a.m. Eastern Daylight Time the same day, featuring commentary from its CEO and CFO, followed by a Q&A session. Investors can join the call via phone or listen to a webcast available on Peoples' website, with the replay accessible for one year. Peoples Bancorp is a diversified financial services company with $9.5 billion in assets and 144 locations across several states as of mid-2026.

Peoples Bancorp Inc. is set to announce its third quarter 2026 earnings on October 20, 2026. For readers following the Financials sector, here is Pluang's market snapshot as of Sep 29, 2026 02:52 WIB: out of 85 priced US Financials stocks tradable on Pluang, 8 rose and 76 fell today. Notable movers include AFRM at USD 67.65 with a 1-day change of -5.41% and Pluang order activity showing 53% Sell / 47% Buy, BTBT at USD 1.68 down 4.55% with 72% Sell / 28% Buy, and LU at USD 1.28 up 4.07% with 76% Sell / 24% Buy. The most notable figure is the 76 stocks that fell today.

More News

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...

Market News
Bearish
1 hour ago
Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...

Market News
Bullish
1 hour ago
Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...

Market News
Bullish
2 hours ago
Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...

Market News
Neutral
2 hours ago
Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App